Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Reliance SARS-CoV-2 RT-PCR Kit (IVD) for ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of an RT-PCR kit that allows researchers to simultaneously screen samples for Zika (ZIKV), dengue (DENV1, DENV2, DENV3, DENV4 ...
HERCULES, Calif. - Bio-Rad Laboratories, Inc. (NYSE:BIO and BIO.B), a life sciences company with a market capitalization of $6.8 billion and strong financial health according to InvestingPro data, ...
現在アクセス不可の可能性がある結果が表示されています。
アクセス不可の結果を非表示にする